These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 34790401)

  • 61. Contrast-enhanced ultrasound using SonoVue® (sulphur hexafluoride microbubbles) compared with contrast-enhanced computed tomography and contrast-enhanced magnetic resonance imaging for the characterisation of focal liver lesions and detection of liver metastases: a systematic review and cost-effectiveness analysis.
    Westwood M; Joore M; Grutters J; Redekop K; Armstrong N; Lee K; Gloy V; Raatz H; Misso K; Severens J; Kleijnen J
    Health Technol Assess; 2013 Apr; 17(16):1-243. PubMed ID: 23611316
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Differentiation between hepatocellular carcinoma and intrahepatic cholangiocarcinoma using contrast-enhanced ultrasound: A systematic review and meta-analysis.
    Chen Y; Zhu Y; Chen K; Wang H; Zhang W; Bao J; Wang W
    Clin Hemorheol Microcirc; 2021; 79(2):293-309. PubMed ID: 33935070
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Significance of Glypican-3 in Early Detection of Hepatocellular Carcinoma in Cirrhotic Patients.
    Tahon AM; El-Ghanam MZ; Zaky S; Emran TM; Bersy AM; El-Raey F; A Z E; El Kharsawy AM; Johar D
    J Gastrointest Cancer; 2019 Sep; 50(3):434-441. PubMed ID: 29623600
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Lack of arterial hypervascularity at contrast-enhanced ultrasound should not define the priority for diagnostic work-up of nodules <2 cm.
    Forner A; Vilana R; Bianchi L; Rodríguez-Lope C; Reig M; García-Criado MÁ; Rimola J; Solé M; Ayuso C; Bru C; Bruix J
    J Hepatol; 2015 Jan; 62(1):150-5. PubMed ID: 25173969
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Unclear focal liver lesions in contrast-enhanced ultrasonography--lessons to be learned from the DEGUM multicenter study for the characterization of liver tumors.
    Bernatik T; Seitz K; Blank W; Schuler A; Dietrich CF; Strobel D
    Ultraschall Med; 2010 Dec; 31(6):577-81. PubMed ID: 20740399
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Usefulness of Imaging and Biological Tools for the Characterization of Portal Vein Thrombosis in Hepatocellular Carcinoma.
    Burciu C; Șirli R; Bende F; Fofiu R; Popescu A; Sporea I; Ghiuchici AM; Miuțescu B; Dănilă M
    Diagnostics (Basel); 2022 May; 12(5):. PubMed ID: 35626300
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Characterization of primary and recurrent nodules in liver cirrhosis using contrast-enhanced ultrasound: which vascular criteria should be adopted?
    Leoni S; Piscaglia F; Granito A; Borghi A; Galassi M; Marinelli S; Terzi E; Bolondi L
    Ultraschall Med; 2013 Jun; 34(3):280-7. PubMed ID: 23616066
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Cytokeratin-18 in Diagnosis of HCC in Patients with Liver Cirrhosis.
    Ismail SA; El Saadany Sh; Ziada DH; Zakaria SS; Mayah WW; Elashry H; Arafa M; Elmashad N
    Asian Pac J Cancer Prev; 2017 Apr; 18(4):1105-1111. PubMed ID: 28547948
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Hepatocellular Carcinoma Surveillance: Benefit of Serum Alfa-fetoprotein in Real-world Practice.
    Lersritwimanmaen P; Nimanong S
    Euroasian J Hepatogastroenterol; 2018; 8(1):83-87. PubMed ID: 29963472
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Contrast-enhanced ultrasonography in peripheral lung consolidations: What's its actual role?
    Sartori S; Postorivo S; Vece FD; Ermili F; Tassinari D; Tombesi P
    World J Radiol; 2013 Oct; 5(10):372-80. PubMed ID: 24179632
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Diagnostic value of glypican-3 in alpha fetoprotein negative hepatocellular carcinoma patients.
    Li B; Liu H; Shang HW; Li P; Li N; Ding HG
    Afr Health Sci; 2013 Sep; 13(3):703-9. PubMed ID: 24250310
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Value of ¹⁸F-FDG-PET/CT in the detection of recurrent hepatocellular carcinoma after hepatectomy or radiofrequency ablation: a comparative study with contrast-enhanced ultrasound.
    Wang XY; Chen D; Zhang XS; Chen ZF; Hu AB
    J Dig Dis; 2013 Aug; 14(8):433-8. PubMed ID: 23615075
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Contrast-Enhanced Ultrasound for the Characterization of Malignant versus Benign Focal Liver Lesions in a Prospective Multicenter Experience - The SRUMB Study.
    Sporea I; Săndulescu DL; Şirli R; Popescu A; Danilă M; Spârchez Z; Mihai C; Ioanițescu S; Moga T; Timar B; Brisc C; Nedelcu D; Săftoiu A; Enăchescu V; Badea R
    J Gastrointestin Liver Dis; 2019 Jun; 28():191-196. PubMed ID: 31204417
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Value of contrast-enhanced ultrasound combined with percutaneous ultrasound-guided fine-needle aspiration in the diagnosis of solid pancreatic lesions.
    Gui Y; Dai M; Meng Z; Chang X; Tan L; Zhang J; Chen X; Zhou T; Zhang Q; Xiao M; Lyu K; Jiang Y
    Chin Med J (Engl); 2021 Nov; 135(4):426-432. PubMed ID: 34759214
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Hepatocellular Carcinoma Automatic Diagnosis within CEUS and B-Mode Ultrasound Images Using Advanced Machine Learning Methods.
    Mitrea D; Badea R; Mitrea P; Brad S; Nedevschi S
    Sensors (Basel); 2021 Mar; 21(6):. PubMed ID: 33801125
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Contrast-Enhanced Ultrasonography for Screening and Diagnosis of Hepatocellular Carcinoma: A Case Series and Review of the Literature.
    McGillen KL; Zaidi S; Ahmed A; Harter S; Yee NS
    Medicines (Basel); 2020 Aug; 7(9):. PubMed ID: 32867068
    [No Abstract]   [Full Text] [Related]  

  • 77. [Screening of hepatocellular carcinoma: role of the alpha-fetoprotein (AFP) and ultrasonography].
    Barletta E; Tinessa V; Daniele B
    Recenti Prog Med; 2005 Jun; 96(6):295-9; quiz 328. PubMed ID: 16078760
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Diagnostic value of PIVKA-II and alpha-fetoprotein in hepatitis B virus-associated hepatocellular carcinoma.
    Seo SI; Kim HS; Kim WJ; Shin WG; Kim DJ; Kim KH; Jang MK; Lee JH; Kim JS; Kim HY; Kim DJ; Lee MS; Park CK
    World J Gastroenterol; 2015 Apr; 21(13):3928-35. PubMed ID: 25852278
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Diagnostic value of AFP-L3 and PIVKA-II in hepatocellular carcinoma according to total-AFP.
    Choi JY; Jung SW; Kim HY; Kim M; Kim Y; Kim DG; Oh EJ
    World J Gastroenterol; 2013 Jan; 19(3):339-46. PubMed ID: 23372355
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Usefulness of contrast-enhanced ultrasound-guided biopsy for suspected viable hepatocellular carcinoma after treatment: a single-arm prospective study.
    Yoo J; Lee DH
    Ultrasonography; 2024 Mar; 43(2):88-97. PubMed ID: 38310870
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.